Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA566812
Max Phase: Preclinical
Molecular Formula: C10H17N2O13P3
Molecular Weight: 466.17
Molecule Type: Small molecule
Associated Items:
ID: ALA566812
Max Phase: Preclinical
Molecular Formula: C10H17N2O13P3
Molecular Weight: 466.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cn([C@H]2CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C10H17N2O13P3/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(23-8)5-22-27(18,19)25-28(20,21)24-26(15,16)17/h4,7-8H,2-3,5H2,1H3,(H,18,19)(H,20,21)(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1
Standard InChI Key: URGJWIFLBWJRMF-JGVFFNPUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 466.17 | Molecular Weight (Monoisotopic): 465.9943 | AlogP: -0.13 | #Rotatable Bonds: 8 |
Polar Surface Area: 223.91 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 0.90 | CX Basic pKa: | CX LogP: -1.38 | CX LogD: -8.79 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.32 | Np Likeness Score: 1.11 |
1. Mansuri MM, Starrett JE, Ghazzouli I, Hitchcock MJ, Sterzycki RZ, Brankovan V, Lin TS, August EM, Prusoff WH, Sommadossi JP.. (1989) 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent., 32 (2): [PMID:2536441] [10.1021/jm00122a029] |
2. Boyer PL, Vu BC, Ambrose Z, Julias JG, Warnecke S, Liao C, Meier C, Marquez VE, Hughes SH.. (2009) The nucleoside analogue D-carba T blocks HIV-1 reverse transcription., 52 (17): [PMID:19678643] [10.1021/jm801176e] |
3. Pryde DC, Webster R, Butler SL, Murray EJ, Whitby K, Pickford C, Westby M, Palmer MJ, Bull DJ, Vuong H, Blakemore DC, Stead D, Ashcroft C, Gardner I, Bru C, Cheung W, Roberts IO, Morton J, Bissell RA. (2013) Discovery of an HIV integrase inhibitor with an excellent resistance profile, 4 (4): [10.1039/C3MD00014A] |
4. Le DH, Takenaka Y, Hamada N, Mizushina Y, Tanahashi T.. (2014) Polyketides from the cultured lichen mycobiont of a Vietnamese Pyrenula sp., 77 (6): [PMID:24926891] [10.1021/np500143k] |
5. Le DH, Nishimura K, Takenaka Y, Mizushina Y, Tanahashi T.. (2016) Polyprenylated Benzoylphloroglucinols with DNA Polymerase Inhibitory Activity from the Fruits of Garcinia schomburgkiana., 79 (7): [PMID:27409517] [10.1021/acs.jnatprod.6b00255] |
6. Zhou S, Mahmoud S, Liu P, Zhou L, Ehteshami M, Bassit L, Tao S, Domaoal RA, Sari O, Schutter C, Amiralaei S, Khalil A, Ollinger Russell O, McBrayer T, Whitaker T, Abou-Taleb N, Amblard F, Coats SJ, Schinazi RF.. (2017) 2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture., 60 (13): [PMID:28595015] [10.1021/acs.jmedchem.7b00067] |
Source(1):